Dafna Capital Management LLC Macrogenics Inc Transaction History

Dafna Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.48 - $10.11 $475,982 - $1.07 Million	-106,246 Reduced 41.1%	152,250 $1.46 Million
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $1.16 Million - $1.6 Million	258,496 New	258,496 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $200,804 - $419,644	-60,121 Reduced 60.12%	39,879 $267,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $276,920 - $480,240	-92,000 Reduced 47.92%	100,000 $346,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $828,239 - $1.72 Million	102,000 Added 113.33%	192,000 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $1.78 Million - $2.58 Million	90,000 New	90,000 $1.89 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $780,000 - $4.37 Million	-150,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $397,500 - $613,500	-50,000 Reduced 25.0%	150,000 $1.63 Million
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $1.87 Million - $2.62 Million	150,000 Added 300.0%	200,000 $2.55 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $314,468 - $724,608	-28,305 Reduced 36.15%	50,000 $899,000
Q2 2018 Aug 13, 2018	SELL	$19.78 - $24.67 $94,944 - $118,416	-4,800 Reduced 5.78%	78,305 $1.62 Million
Q1 2018 May 15, 2018	SELL	$18.89 - $32.46 $1.34 Million - $2.31 Million	-71,095 Reduced 46.11%	83,105 $2.09 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $2.39 Million - $2.92 Million	154,200	154,200 $2.85 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.